Trump to sign law allowing FTC to scrutinize biosimilar deals

Trump to sign law allowing FTC to scrutinize biosimilar deals

Source: 
Biopharma Dive
snippet: 

President Donald Trump will sign a bill into law Wednesday requiring drugmakers to send details of biosimilar deals to the Federal Trade Commission for antitrust scrutiny.